SPPI News and Press, Spectrum Pharmaceuticals Inc. From 01/20/22

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will participate in the B. Riley Securities 2022 Virtual Oncology Conference. A fireside chat is scheduled for Thursday, January 27, 2...

Workforce reduction of approximately 30% Cash runway extended into 2023 Resources to be focused on late-stage assets, poziotinib and ROLONTIS ® Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and ta...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a $20 million equity investment by Hanmi Pharmaceutical along with revisions to the licensing agreements for ROLONTIS ® (eflapegrastim) and p...

5 More Penny Stocks To Watch With High Short Interest There are plenty of trends to follow in the stock market, especially when it comes to penny stocks. We’ve seen industry themes like DeFi, NFTs, and digital currency grow in popularity this quarter. We’ve also seen b...

Fast Track application is based on positive data in NSCLC HER2 exon 20 insertion mutations in previously treated patients Positive Results for Cohort 2 of ZENITH20 clinical trial published in Journal of Clinical Oncology Spectrum Pharmaceuticals (NasdaqGS: SP...

Penny Stocks To Buy For Under $5; Are They Worth The Risk? There are so many traders in the stock market today searching for top penny stocks to buy. These high-risk assets have been a source for some of the biggest winning trades over the last few years. I’m not only talking abo...

Spectrum Pharmaceuticals (NASDAQ:SPPI) announces that its President and CEO Joseph Turgeon will retire from the company effective Dec. 31. Upon his departure, Tom Riga, currently the Chief Commercial and Chief Operating Officer will take over the role and join the board of directors. Having j...

Tom Riga named President and Chief Executive Officer and will join the Board of Directors effective December 31, 2021 Joe Turgeon, President and Chief Executive Officer, to retire and step down from Board of Directors Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), ...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will participate in the JMP Securities Hematology and Oncology Summit, a virtual presentation is scheduled for Tuesday, December 7, 20...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will participate in the 2021 Jefferies London Healthcare Conference. A virtual fireside chat will be available to conference attendees...